Korea's GC Cell and Israel-based QuantHealth collaborate to optimise clinical cevelopment of cell therapy product

Singapore, Oct. 8 -- South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and Israel-based QuantHealth, the global leader in AI-powered ... Read More

Japan's Shionogi continues rare disease expansion with acquisition of IntraBio for $2 B

Singapore, Oct. 8 -- Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company developing and commercialising therapies for neurodegenerative diseas... Read More

GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US

Singapore, Oct. 8 -- GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase ... Read More

Charles River and Autolomous launch Apollo Orchestrate for digital laboratory execution

Singapore, Oct. 8 -- Charles River Laboratories International, Inc. and Autolomous announced the launch of Apollo Orchestrate on October 6, 2026, a new capability within Charles River's Apollo platfor... Read More

Japan's Third Way: BioJapan Day 2 Maps the Routes Out and the Reasons to Come In

Singapore, Oct. 8 -- If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIFICO Yokohama got down to the practical business of closing ... Read More

Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies

Singapore, Oct. 8 -- Andelyn Biosciences ("Andelyn"), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), and PQP Group announced a s... Read More

Novartis signs licensing deal worth $7.2 B with China's Abogen for mRNA therapies

Singapore, Oct. 7 -- China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a licensing and option agreement with Novartis to advance ... Read More

AstraZeneca opens new global strategic R&D centre in Massachusetts, US

Singapore, Oct. 7 -- AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US. The new state-of-the-... Read More

Docquity extends Asian healthcare intelligence to Japan through deepened strategic partnership with exMedio

Singapore, Oct. 7 -- Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced its scale up plan into Japan through a deepened strategic partn... Read More

Qiagen expands AI-powered bioinformatics for research and drug discovery

Singapore, Oct. 7 -- Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and genomic data faster while keeping the scientific evidence beh... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»